1. Baker, W. W., Connor, J. D., Rossi, G. V. and Lalley, P. M. (1969). In Barbeau, A. and Brunette, J. R. (eds), Progress in Neurogenetics, vol. 1, Excerpta Medica, Amsterdam, pp. 390–408.
2. Baker, W. W., Lalley, P. M., Connor, J. D. and Rossi, G. V. (1976). Neuropharmacologic analysis of cholinergic tremor mechanisms in the caudate nucleus. Pharmacol. Ther. C: Clin. Pharmacol. Ther., 1, 459–73.
3. Barbeau, A. (1962). The pathogenesis of Parkinson’s disease: a new hypothesis. Can. Med. Assoc. J., 87, 802–7.
4. Battista, A. F., Nakatani, S., Goldstein, M. and Anagnoste, G. (1970). Effect of harmaline in monkeys with central nervous system lesions. Exp. Neurol., 28, 513–24.
5. Bedard, P., Larochelle, L., Poirier, L. J. and Sourkes, T. L. (1970). Reversible effect of L-dopa on tremor and catatonia induced by α-methyl-p-tyrosine. J. Physiol. Pharmacol., 48, 82–4.